skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice

Journal Article · · Toxicology and Applied Pharmacology
; ;  [1];  [2]; ; ;  [1];  [3];  [4];  [1]
  1. College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742 (Korea, Republic of)
  2. School of Pharmacy, Sungkyunkwan University, Suwon 440-746 (Korea, Republic of)
  3. The Division of Natural Medical Sciences, College of Health Science, Chosun University, Gwangju 501-759 (Korea, Republic of)
  4. Internal Medicine, Hanyang University School of Medicine, Seoul 133-791 (Korea, Republic of)

Emerging evidence has shown that berberine has a protective effect against metabolic syndrome such as obesity and type II diabetes mellitus by activating AMP-activated protein kinase (AMPK). AMPK induces CD36 trafficking to the sarcolemma for fatty acid uptake and oxidation in contracting muscle. However, little is known about the effects of AMPK on CD36 regulation in the liver. We investigated whether AMPK activation by berberine affects CD36 expression and fatty acid uptake in hepatocytes and whether it is linked to hepatic lipid accumulation. Activation of AMPK by berberine or transduction with adenoviral vectors encoding constitutively active AMPK in HepG2 and mouse primary hepatocytes increased the expression and membrane translocation of CD36, resulting in enhanced fatty acid uptake and lipid accumulation as determined by BODIPY-C16 and Nile red fluorescence, respectively. Activation of AMPK by berberine induced the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2) and subsequently induced CCAAT/enhancer-binding protein β (C/EBPβ) binding to the C/EBP-response element in the CD36 promoter in hepatocytes. In addition, hepatic CD36 expression and triglyceride levels were increased in normal diet-fed mice treated with berberine, but completely prevented when hepatic CD36 was silenced with adenovirus containing CD36-specific shRNA. Taken together, prolonged activation of AMPK by berberine increased CD36 expression in hepatocytes, resulting in fatty acid uptake via processes linked to hepatocellular lipid accumulation and fatty liver. - Highlights: • Berberine increases the expression and membrane translocation of CD36 in hepatocytes. • The increase of CD36 results in enhanced fatty acid uptake and lipid accumulation. • Berberine-induced fatty liver is mediated by AMPK-ERK-C/EBPβ pathway. • CD36-specific shRNA inhibited berberine-induced lipid accumulation in liver.

OSTI ID:
22690914
Journal Information:
Toxicology and Applied Pharmacology, Vol. 316; Other Information: Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77
Journal Article · Mon Jan 15 00:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:22690914

Honokiol activates the LKB1–AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes
Journal Article · Wed Apr 15 00:00:00 EDT 2015 · Toxicology and Applied Pharmacology · OSTI ID:22690914

Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis
Journal Article · Thu Jun 01 00:00:00 EDT 2017 · Toxicology and Applied Pharmacology · OSTI ID:22690914